Literature DB >> 8957220

Vincamine and vincanol are potent blockers of voltage-gated Na+ channels.

S A Erdo1, P Molnár, V Lakics, J Z Bence, Z Tömösközi.   

Abstract

The effects of three vinca derivatives on [3H]batrachotoxin binding in rat cortical synaptosomes, on the inhibition of whole-cell Na+ currents evoked in voltage-clamped cortical neurones of the rat, on the protection against veratridine-induced cell death in cortical cultures and on the maximal electroshock-induced seizures in mice were compared. Vinpocetine, vincamine and vincanol reduced [3H]batrachotoxin binding with IC50 values of 0.34, 1.9 and 10.7 microM, blocked Na+ currents with IC50 values of 44.72 and 40 microM, and protected cortical against veratridine-induced cell death with IC50 values of 0.49, 26 and 33 microM, respectively. Upon i.p. administration, vinpocetine, vincamine and vincanol attenuated maximal electric shock-induced convulsions in a dose-dependent manner with ED50 values of 27, 15.4 and 14.6 mg/kg, respectively. The present findings indicate that the three vinca derivatives are potent blockers of voltage-gated Na+ channels, a mechanism that may contribute at least in part to the pharmacological/therapeutic benefit of these drugs.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8957220     DOI: 10.1016/s0014-2999(96)00542-0

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  7 in total

Review 1.  The role of phytochemicals in the treatment and prevention of dementia.

Authors:  Melanie-Jayne R Howes; Elaine Perry
Journal:  Drugs Aging       Date:  2011-06-01       Impact factor: 3.923

2.  Vinpocetine selectively inhibits neurotransmitter release triggered by sodium channel activation.

Authors:  M Sitges; V Nekrassov
Journal:  Neurochem Res       Date:  1999-12       Impact factor: 3.996

3.  Proton speciation and microspeciation of vinpocetine and related compounds in aqueous and biomimetic media.

Authors:  K Mazák; A Nemes; B Noszál
Journal:  Pharm Res       Date:  1999-11       Impact factor: 4.200

4.  The nootropic drug vinpocetine inhibits veratridine-induced [Ca2+]i increase in rat hippocampal CA1 pyramidal cells.

Authors:  T Zelles; L Franklin; I Koncz; B Lendvai; G Zsilla
Journal:  Neurochem Res       Date:  2001-09       Impact factor: 3.996

5.  Neuroprotective effects of vinpocetine and its major metabolite cis-apovincaminic acid on NMDA-induced neurotoxicity in a rat entorhinal cortex lesion model.

Authors:  Csaba Nyakas; Klára Felszeghy; Róbert Szabó; Jan N Keijser; Paul G M Luiten; Zsolt Szombathelyi; Károly Tihanyi
Journal:  CNS Neurosci Ther       Date:  2009       Impact factor: 5.243

6.  The Mitochondrial Targets of Neuroprotective Drug Vinpocetine on Primary Neuron Cultures, Brain Capillary Endothelial Cells, Synaptosomes, and Brain Mitochondria.

Authors:  Gergely Svab; Judit Doczi; Akos A Gerencser; Attila Ambrus; Ferenc Gallyas; Balazs Sümegi; László Tretter
Journal:  Neurochem Res       Date:  2019-09-18       Impact factor: 3.996

Review 7.  Nootropics as Cognitive Enhancers: Types, Dosage and Side Effects of Smart Drugs.

Authors:  Matěj Malík; Pavel Tlustoš
Journal:  Nutrients       Date:  2022-08-17       Impact factor: 6.706

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.